Panbela Therapeutics

Focus: Panbela Therapeutics is a small molecule-focused biotechnology company headquartered in Waconia, Minnesota. Limited public information available regarding market position and current scale.

Oncology

Profile data last refreshed 20h ago · AI intelligence enriched 1w ago

Open Jobs

About Panbela Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Panbela Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

SBP-101

Pancreatic Cancer

Phase 1

Clinical Trials (1)

NCT02657330Study of SBP-101 in Pancreatic Cancer

Phase 1

Help build intelligence for Panbela Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Small molecule focus offers chemistry and medicinal chemistry skill development in an emerging company
Early-stage biotech environment provides opportunity to shape company direction and take on diverse responsibilities
Minnesota location offers lower cost of living than major pharma hubs while building emerging biotech ecosystem

Watch Out For

No active job openings currently listed, indicating minimal near-term hiring activity
Lack of public financial data, pipeline visibility, or clinical trial activity raises questions about development progress and funding stability
Pre-revenue stage carries inherent funding and sustainability risk without evidence of product advancement or cash runway

Generated by Claude from Panbela Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

SBP-101

Pancreatic Cancer Metastatic

Phase 1

Clinical Trials (1)

NCT03412799Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Phase 1

DFMO

Prostate Cancer

Phase 2

Clinical Trials (1)

NCT06059118Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 2

SBP-101

Pancreatic Cancer Metastatic

Phase 2/3

Clinical Trials (1)

NCT05254171Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Phase 2/3

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 4 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

4 pipeline

Marketed

Pipeline